NCT04824274

Brief Summary

This noninferiority study aims to determine whether transversus abdominis plane (TAP) block with intrathecal fentanyl could provide a noninferior analgesia compared with intrathecal morphine after cesarean delivery under spinal anesthesia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 19, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 1, 2021

Completed
11 days until next milestone

Study Start

First participant enrolled

April 12, 2021

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2022

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 20, 2022

Completed
Last Updated

February 24, 2022

Status Verified

February 1, 2022

Enrollment Period

10 months

First QC Date

March 19, 2021

Last Update Submit

February 22, 2022

Conditions

Keywords

transversus abdominis plane blockmorphinefentanylspinal anesthesiacesarean sectionpostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Pain score with movement at 24 hours after delivery

    Pain score with movement at 24hr after delivery, using 11-point Numeric rating scale (0, no pain; 10, the worst pain imaginable)

    at 24 hours after delivery

Secondary Outcomes (18)

  • Intravenous fentanyl consumption

    at 6, 12, 18, 24, 48 hours after delivery

  • Pain score at rest

    at 6, 12, 18, 24, 48 hours after delivery

  • Pain score with movement

    at 6, 12, 18, 48 hours after delivery

  • time to first opioid request

    during hospital stay, an average of 3 days

  • number of patients requiring rescue analgesics

    During the first 48 hour-period after delivery

  • +13 more secondary outcomes

Study Arms (2)

Transversus abdominis plane block and intrathecal fentanyl

EXPERIMENTAL

Patients will receive spinal anesthesia with 0.5% bupivacaine 9 mg + fentanyl 10 mcg. Following the completion of surgery, ultrasound-guided bilateral transversus abdominis plane block will be done with 0.375% ropivacaine 15 ml per each side.

Drug: fentanylProcedure: Transversus abdominis plane block

Intrathecal morphine

ACTIVE COMPARATOR

Patients will receive spinal anesthesia with 0.5% bupivacaine 9 mg + morphine 75 mcg. Following the completion of surgery, sham block will be done using normal saline.

Drug: morphineProcedure: Sham block

Interventions

Fentanyl 10 mcg will be injected intrathecally during spinal anesthesia.

Transversus abdominis plane block and intrathecal fentanyl

Morphine 75 mcg will be injected intrathecally during spinal anesthesia.

Also known as: Morphine sulfate
Intrathecal morphine

Ultrasound-guided bilateral transversus abdominis plane block will be done. 0.375% ropivacaine 15 ml per side will be injected.

Transversus abdominis plane block and intrathecal fentanyl
Sham blockPROCEDURE

Ultrasound-guided bilateral transversus abdominis plane sham block will be done. Normal saline 15 ml per side will be injected.

Intrathecal morphine

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult full-term parturients scheduled to undergo elective cesarean delivery under spinal anesthesia

You may not qualify if:

  • Contraindication to spinal anesthesia
  • Any chronic pain unrelated pregnancy
  • current opioid medication use
  • BMI more than 40 kg m-2
  • History of drug allergy or hypersensitivity to fentanyl, morphine, ropivacaine, acetaminophen, NSAIDs, bupivacaine, ramosetron, ondansetron, nalbuphine, Naloxone, metoclopramide
  • infection of abdominal wall
  • Pregnancy-induced hypertension
  • known cardiovascular disease
  • Known fetal anomaly
  • Any sign of onset of labor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Jin-Tae Kim

Seoul, South Korea

Location

Related Publications (4)

  • Cole J, Hughey S, Longwell J. Transversus abdominis plane block and intrathecal morphine use in cesarean section: a retrospective review. Reg Anesth Pain Med. 2019 Sep 13:rapm-2019-100483. doi: 10.1136/rapm-2019-100483. Online ahead of print.

    PMID: 31519816BACKGROUND
  • Patel SD, Sharawi N, Sultan P. Local anaesthetic techniques for post-caesarean delivery analgesia. Int J Obstet Anesth. 2019 Nov;40:62-77. doi: 10.1016/j.ijoa.2019.06.002. Epub 2019 Jun 8.

    PMID: 31262444BACKGROUND
  • Kwikiriza A, Kiwanuka JK, Firth PG, Hoeft MA, Modest VE, Ttendo SS. The analgesic effects of intrathecal morphine in comparison with ultrasound-guided transversus abdominis plane block after caesarean section: a randomised controlled trial at a Ugandan regional referral hospital. Anaesthesia. 2019 Feb;74(2):167-173. doi: 10.1111/anae.14467. Epub 2018 Nov 1.

    PMID: 30383289BACKGROUND
  • Park SK, Kim Y, Kim H, Kim JT. Transversus abdominis plane block combined with intrathecal fentanyl versus intrathecal morphine for post-cesarean analgesia: a randomized non-inferiority clinical trial. Reg Anesth Pain Med. 2025 Jan 21:rapm-2024-106044. doi: 10.1136/rapm-2024-106044. Online ahead of print.

MeSH Terms

Interventions

FentanylMorphine

Intervention Hierarchy (Ancestors)

PiperidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsMorphine DerivativesMorphinansOpiate AlkaloidsAlkaloidsHeterocyclic Compounds, Bridged-RingHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingPhenanthrenesPolycyclic Aromatic HydrocarbonsPolycyclic Compounds

Study Officials

  • Jin-Tae Kim, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

March 19, 2021

First Posted

April 1, 2021

Study Start

April 12, 2021

Primary Completion

February 18, 2022

Study Completion

February 20, 2022

Last Updated

February 24, 2022

Record last verified: 2022-02

Locations